GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Lisinopril

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

The source contains a malformed comparison in its low-pressure myocardial-infarction initiation sentence. Do not use that sentence as an executable algorithm; consult current labeling.

Check source scope before reading a dose

Lisinopril - conventional oral tablets

Product / population
Adults; conventional oral lisinopril tablets, indication-specific starting doses.
Renal method
Creatinine clearance, mL/min
Source revision
9/2021
Retrieved
2026-09-10
Local review status
Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Before use: Lisinopril

Starting doses agree in selected sections; clinical context still controls titration.

What to reconcile: Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Source-specific interpretation; independent clinician adjudication pending.

Open this note and its source references
Official

Lisinopril - conventional oral tablets

Open original reference

DailyMed / NLM exact product labeling · Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Renal method: Creatinine clearance, mL/min
Source date: 9/2021
Retrieved: 2026-09-10

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Dialysis evidence: A dialysis-population initial dose is reported; maintenance requires titration

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Adult renal starting-dose instruction
CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily
Read the retained text before reformatting

Adult renal starting-dose instruction

CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

RDM63-official-lisinopril-d717d46070-C1 · Source locator: Dose in patients with renal impairment; official section 2.4; warnings 5.1-5.5

Source-specific limits

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f20acd7-2635-4a9b-b732-2a84ea93dea7
Retrieved
2026-09-10
Exact label title
Lisinopril - conventional oral tablets
DailyMed Set ID
8f20acd7-2635-4a9b-b732-2a84ea93dea7
Label revision
9/2021
Renal-function method
Creatinine clearance, mL/min
Source date/version
9/2021
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
fe077fc4ffc55b1990a5bde30c59c93bf32dc66e16a33d843e20d359e9557ba2

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=lisinopril&s1=RDM63-official-lisinopril-d717d46070&h1=aa94090f87bac0d52df006b9bac1ff80dc1e9f2f14ee1fad0d107903fc49a7b3